Soluble CD40 ligand and endothelial dysfunction in aspirin-treated polycythaemia vera patients.
Lessiani
Gianfranco
G
Centre of Excellence on Aging, G d'Annunzio University Foundation, Chieti, Italy.
Dragani
Alfredo
A
Falco
Angela
A
Fioritoni
Francesca
F
Santilli
Francesca
F
Davì
Giovanni
G
D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D023201:CD40 Ligand / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015539:Platelet Activation; D011087:Polycythemia Vera / Q000097:blood* / Q000188:drug therapy*; D018709:Statistics, Nonparametric; D014664:Vasodilation / Q000187:drug effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D023201:CD40 Ligand; D001241:Aspirin